We may soon be facing the end of the “antibiotic era.” The initial and seemingly unstoppable
success of antibiotics, the fruit of human ingenuity, has been countered by an escalation of …

Infection due to Acinetobacter baumannii has become a significant challenge to modern
healthcare systems. The organism shows a formidable capacity to develop antimicrobial …

To understand the epidemiology of multidrug-resistant (MDR) Acinetobacter baumannii and
define individual risk factors for MDR, we used epidemiologic methods, performed organism …

Amid the recent attention focused on the growing impact of methicillin-resistant
Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa infections, the …

Acinetobacter spp. are Gram-negative bacteria that have become one of the most difficult
pathogens to treat. The species A. baumannii, largely unknown 30 years ago, has risen to …

Abstract Purpose of Review Acinetobacter baumannii (AB) is an infamous nosocomial
pathogen with a seemingly limitless capacity for antimicrobial resistance, leading to few …

Multidrug-resistant Acinetobacter baumannii is recognized to be among the most difficult
antimicrobial-resistant gram-negative bacilli to control and treat. Increasing antimicrobial …

Acinetobacter baumannii, once considered a low-category pathogen, has emerged as an
obstinate infectious agent. The scientific community is paying more attention to this …

Acinetobacter baumannii, recognized as a serious threat in healthcare facilities, has the
ability to develop resistance to antibiotics quite easily. This resistance is related to either …

Acinetobacter baumannii is undoubtedly one of the most successful pathogens responsible
for hospital-acquired nosocomial infections in the modern healthcare system. Due to the …